Advertisement
Letter to the Editor| Volume 61, ISSUE 2, P191-192, February 2023

Download started.

Ok

Re: Re: Transdermal fentanyl patch versus standard analgesia in postoperative oral submucous fibrosis patients: A triple blinded, randomised control trial

Published:January 10, 2023DOI:https://doi.org/10.1016/j.bjoms.2022.12.009
      We feel grateful for some additional comments focused in the letter to the editor in response to our study published on the comparison of transdermal fentanyl patch versus standard analgesia in postoperative oral submucous fibrosis (OSMF).
      • Nihadha P.M.
      • Chugh A.
      • Kaur A.
      • et al.
      Transdermal fentanyl patch versus standard analgesia in postoperative oral submucous fibrosis patients: a triple blinded, randomised control trial.
      The few points raised in the letter to the editor overshadows the fact of the understanding of the original article by the authors and led to further confusion.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to British Journal of Oral and Maxillofacial Surgery
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Nihadha P.M.
        • Chugh A.
        • Kaur A.
        • et al.
        Transdermal fentanyl patch versus standard analgesia in postoperative oral submucous fibrosis patients: a triple blinded, randomised control trial.
        Br J Oral Maxillofac Surg. 2022; 60: 1246-1253
        • More C.B.
        • Das S.
        • Patel H.
        • et al.
        Proposed clinical classification for oral submucous fibrosis.
        Oral Oncol. 2012; 48: 200-202
        • Kale S.
        • Srivastava N.
        • Bagga V.
        • et al.
        Effectiveness of long term supervised and assisted physiotherapy in postsurgery oral submucous fibrosis patients.
        Case Rep Dent. 2016; 2016: 6081905
        • Borle R.M.
        • Nimonkar P.V.
        • Rajan R.
        Extended nasolabial flaps in the management of oral submucous fibrosis.
        Br J Oral Maxillofac Surg. 2009; 47: 382-385
        • Shunmugavelu K.
        • Subramaniam K.
        Surgical management of recurrent oral submucous fibrosis ( a collagen metabolic disorder due to the continuation of habitual factor) by split thickness skin graft from thigh: a clinical challenge.
        Saint’s Int Dental J. 2016; 2: 53-56
        • Kauser D.
        • Singh D.
        Comparisons of Transdermal Buprenorphine Patch versus Transdermal Fentanyl patch for postoperative analgesia in lower limb orthopedic surgery.
        Indian J Public Health Res Develop. 2022; 13: 91-94
        • Matsumoto S.
        • Matsumoto K.
        • Iida H.
        Transdermal fentanyl patch improves post-operative pain relief and promotes early functional recovery in patients undergoing primary total knee arthroplasty: a prospective, randomised, controlled trial.
        Arch Orthop Trauma Surg. 2015; 135: 1291-1297
        • Hemati K.
        • Zaman B.
        • Hassani V.
        • et al.
        Efficacy of fentanyl transdermal patch in the treatment of chronic soft tissue cancer pain.
        Anesth Pain Med. 2015; 5: e22900
        • Krauss W.C.
        • Shah S.
        • Shah S.
        • et al.
        Fentanyl in the out-of-hospital setting: variables associated with hypotension and hypoxemia.
        J Emerg Med. 2011; 40: 182-187